Protara Therapeutics, Inc.·4

Jan 20, 4:00 PM ET

Fry Hannah 4

4 · Protara Therapeutics, Inc. · Filed Jan 20, 2023

Insider Transaction Report

Form 4
Period: 2023-01-19
Fry Hannah
VP, Controller
Transactions
  • Award

    Common Stock

    2023-01-19+5,90033,139 total
  • Award

    Stock Option (Right to Buy)

    2023-01-19+35,40035,400 total
    Exercise: $3.02Exp: 2033-01-18Common Stock (35,400 underlying)
Footnotes (2)
  • [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2023.
  • [F2]25% of the shares vest on the one year anniversary of January 19, 2023 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Documents

1 file
  • 4
    ownership.xmlPrimary